Broad coverage of genetically diverse strains of Clostridium difficile by actoxumab and bezlotoxumab predicted by in vitro neutralization and epitope modeling.
Saved in:
| Title: | Broad coverage of genetically diverse strains of Clostridium difficile by actoxumab and bezlotoxumab predicted by in vitro neutralization and epitope modeling. |
|---|---|
| Authors: | Hernandez LD; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Racine F; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Xiao L; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., DiNunzio E; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Hairston N; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Sheth PR; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Murgolo NJ; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Therien AG; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA alex_therien@merck.com. |
| Source: | Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2015 Feb; Vol. 59 (2), pp. 1052-60. Date of Electronic Publication: 2014 Dec 01. |
| Publication Type: | Clinical Trial, Phase II; Journal Article |
| Journal Info: | Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
